
CAS Name: (1-Methyl-2-phenoxyethyl)hydrazine
Additional Names: fenoxypropazine
Percent Composition: C 65.03%, H 8.49%, N 16.85%, O 9.63%
Literature References: Prepn: Drain et al., J. Med. Chem. 6, 63 (1963).
CAS Name: Ethyl 3,5,6-tris-O-(phenylmethyl)-D-glucofuranosideTrademarks: Alven (Firma); Flebosan (Dukron); Glyvenol (Novartis); Hemocuron (Takeda); Venex (Recordati)
Percent Composition: C 72.7...
Literature References: Prepn: Druey, Huber, US 3157634 (1964 to Ciba). Pharmacology: Lecomte, C.R. Seances Soc. Biol. Ses Fil. 163, 1469 (1969); Helfer, Jaques, Pharmacology 5, 23 (1971). Increase in capillary resistance in patients with rheumatoid arthritis: W. C. Dick et al., Ann. Rheum. Dis. 28, 187 (1969). GLC determn in plasma: A. Sioufi, F. Pommier, J. Pharm. Sci. 69, 167 (1980). Excretion as hippuric acid: eidem, Eur. J. Drug Metab. Pharmacokinet. 7, 223 (1982). Review of pharmacology: R. Jaques, ibid. 15, 445-460 (1977).
CAS Name: 5-Fluoro-2,4(1H,3H)-pyrimidinedione
Additional Names: 2,4-dioxo-5-fluoropyrimidine; 5-FUTrademarks: Adrucil (Adria); Arumel (SS Pharm.); Efudex (Roche); Efudix (Roche); Fluril; Flurac...
Literature References: Prepn: Duschinsky et al., J. Am. Chem. Soc. 79, 4559 (1957); Heidelberger, Duschinsky, US 2802005 (1957); US 2885396 (1959); Barton et al., J. Org. Chem. 37, 329 (1972); O. Miyashita et al., Chem. Pharm. Bull. 29, 3181 (1981). Pharmacokinetics: W. Sadee, C. G. Wong, Clin. Pharmacokinet. 2, 437 (1977). Site of action: F. Maley, G. F. Maley, FEBS Symp. 57, 21 (1979). Comprehensive description: B. C. Rudy, B. Z. Senkowski, Anal. Profiles Drug Subs. 2, 221-244 (1973); S. M. Bayomi, A. A. Al-Badr, ibid. 18, 599-639 (1989). Review of clinical trials: R. M. Hansen, Cancer Invest. 9, 637-642 (1991).
CAS Name: 4-Amino-5-fluoro-2(1H)-pyrimidinone
Additional Names: 5-fluorocytosine; 5-FCTrademarks: Alcobon (Roche); Ancobon (Roche); Ancotil (Roche)
Percent Composition: C 37.22%, H 3.12%, F ...
Literature References: Prepn: Duschinsky et al., J. Am. Chem. Soc. 79, 4559 (1957); Heidelberger, Duschinsky, US 2802005 (1957); Duschinsky, Heidelberger, US 2945038 and Duschinsky, US 3040026 (1960, 1962 both to Hoffmann-La Roche); Undheim, Gacek, Acta Chem. Scand. 23, 294 (1969). Patents as a fungicide: Berger, Duschinsky, BE 628615 and US 3368938 (1963, 1968 both to Hoffmann-La Roche). Activity studies: Grunberg et al., Antimicrob. Agents Chemother. 1963, 566; Shadomy et al., ibid. 1968, 452; Grunberg et al., in 5th Int. Congr. Chemother., Proc. vol. IV, K. Spitzy, Ed. (Verlag Wiener Med. Akad., 1967, Austria) p 69. Metabolic studies: Koechlin et al., Biochem. Pharmacol. 15, 435 (1966). Clinical results: Utz et al., Antimicrob. Agents Chemother. 1968, 344; Warner et al., ibid. 1970, 473. Comprehensive description: E. H. Waysek, J. H. Johnson, Anal. Profiles Drug Subs. 5, 115-138 (1976).
CAS Name: 1-(2-Bromo-1,2-diphenylethenyl)-4-ethylbenzene
Additional Names: 1-bromo-2-(p-ethylphenyl)-1,2-diphenylethylene; 1-bromo-2-(4-ethylphenyl)-1,2-diphenylethene; a-bromo-a,b-diphenyl-b-(...
Literature References: Prepn: Dvolaitsky, Jacques, Bull. Soc. Chim. Biol. 40, 939 (1958).
CAS Name: p-Aminobenzoic acid potassium salt
Additional Names: potassium para-aminobenzoate; KPABA
Trademarks: Potaba (Glenwood)
Percent Composition: C 47.98%, H 3.45%, K 22.31%, N 7.99%,...
Literature References: Prepn: E. A. Meyers et al., J. Am. Chem. Soc. 89, 3565 (1967). Crystal structure: G. S. Ciminago, C.R. Seances Acad. Sci. Ser. C 267, 1402 (1968). Antifibrotic efficacy in idiopathic pulmonary fibrosis: U. H. Cegla et al., Pneumonologie 152, 75 (1975); in Peyronie's disease: A. J. Riley, Br. J. Sex. Med. 6, 29 (1970); G. Williams, N. A. Green, Br. J. Urol. 52, 392 (1980).
CAS Name: a-[[(2-Hydroxy-1,1-dimethylethyl)amino]methyl]benzenemethanol
Additional Names: 1-phenyl-2-(a,a-dimethylethanolamino)ethanol
Percent Composition: C 68.87%, H 9.15%, N 6.69%, O 15.2...
Literature References: Prepn: E. Biekert, J. Sonnenbichler, Ber. 95, 1451 (1962); G. Staibano, C. Protto, Farmaco Ed. Sci. 27, 929 (1972); G. Staibano, BE 774629 (1972 to Gentili). Pharmacology: J. M. Masso et al., J. Pharm. Pharmacol. 45, 959 (1993). Mechanism of action study: eidem, Arzneim.-Forsch. 44, 68 (1994). Clinical trial: C. Bestit et al., Curr. Ther. Res. 45, 53 (1989).
CAS Name: (3-Chlorophenyl)carbamic acid 1-methylethyl ester
Additional Names: m-chlorocarbanilic acid isopropyl ester; isopropyl-m-chlorocarbanilate; isopropyl N-(3-chlorophenyl)carbamate; chlo...
Literature References: Prepn: E. D. Witman, US 2695225; Strain, US 2734911 (1954, 1956 both to Columbia-Southern Chem.); Brockway, US 2806051 (1957 to B. F. Goodrich). Toxicology: E. M. Boyd, E. Carsky, Arch. Environ. Health 19, 621 (1969).
CAS Name: 2-Methylaminoethanesulfonic acid
Additional Names: b-methylaminoethane-a-sulfonic acid
Percent Composition: C 25.89%, H 6.52%, N 10.06%, O 34.49%, S 23.04%
Literature References: Prepn: E. Dittrich, J. Prakt. Chem. 18, 63 (1878); J. W. Schick, E. F. Degering, Ind. Eng. Chem. 39, 906 (1947).
CAS Name: 3-Methyl-2-butanone
Additional Names: 2-acetylpropane
Percent Composition: C 69.72%, H 11.70%, O 18.58%
Literature References: Prepn: E. Frankland, B. F. Duppa, Ann. 138, 328 (1866). Large scale prepn: T. W. Mears et al., J. Res. Natl. Bur. Stand. 44, 299 (1950). Miscibility profile: W. M. Jackson, J. S. Drury, Ind. Eng. Chem. 51, 1491 (1959). Thermodynamic properties: J. L. Hales et al., Trans. Faraday Soc. 63, 1876 (1967). Acute toxicity: H. Tanii et al., Toxicol. Lett. 30, 13 (1986).
即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.
试运营阶段,所有广告业务5折优惠
